tirzepatide news october 2025 Breaking News: Compounding Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's decision to restrict compounding pharmacies from producing tirzepatide, the September 2, 2025: U.S. compounding

460 In a separate clinical trial, the safety, tolerability, and effectiveness of Revacept (40 or 120 mg) were evaluated in individuals with carotid artery stenosis, transient ischemic attack (TIA), transient blackout, or stroke

In the 72-week study, people taking tirzepatide lost around 20% of their body weight on average

What is Novo Nordisk really asking for Novo Nordisk is asking the FDA to crack down on unapproved, cheaper versions of weight loss drugs

Patients interested in checking their insurance coverage can use Ro's GLP-1 Insurance Checker -- a free tool that has helped over 2 million people understand their benefits and get their medication at the lowest possible price whether that's using insurance coverage or paying cash

Its bite isnt deadly to humans, but its painfuland it comes with an unusual payload: a peptide in its venom that mimics a hormone found in the human gut

Either way, you get a named, verifiable pharmacy rather than an anonymous partner